De Rosa M, Giordano S, Scettri A, Sodano G, Soriente A, Pastor P G, Alcaraz M J, Payá M
Dipartimento di Chimica, Università di Salerno, Via S. Allende, 84081 Baronissi (SA), Italy.
J Med Chem. 1998 Aug 13;41(17):3232-8. doi: 10.1021/jm980027h.
We have synthesized analogues of two naturally occurring antiinflammatory marine compounds, manoalide and cacospongionolide B, containing a pyranofuranone moiety which is considered the pharmacophoric group. The two compounds, and hence their analogues, differ in the presence or absence in the dihydropyran ring of an hemiacetal function which was considered essential to irreversibly inactivate phospholipase A2 (PLA2). The two series of compounds were tested for their inhibitory effects on secretory PLA2 belonging to the groups I, II, and III, and the activities were found to be similar in both series, irrespective of the presence or absence of the additional hemiacetal function. In addition, the PLA2 inhibitory activity increases with the increasing hydrophobic character of the side chain linked to the pyranofuranone moiety. The most active compounds, FCA and FMA, carry a farnesyl residue linked to the pyranofuranone substructure. The most potent PLA2 inhibitor, FMA, was tested in the mouse carrageenan paw edema at the oral dose of 10 mg/kg and showed an activity similar to the reference antiinflammatory drug, indomethacin.
我们合成了两种天然存在的抗炎海洋化合物——软海绵素和海绵硬蛋白B的类似物,它们含有一个被认为是药效基团的吡喃并呋喃酮部分。这两种化合物及其类似物的区别在于二氢吡喃环中是否存在半缩醛官能团,该官能团被认为对不可逆地使磷脂酶A2(PLA2)失活至关重要。对这两个系列的化合物进行了对I、II和III组分泌型PLA2的抑制作用测试,发现两个系列的活性相似,与是否存在额外的半缩醛官能团无关。此外,PLA2抑制活性随着与吡喃并呋喃酮部分相连的侧链疏水特性的增加而增强。活性最高的化合物FCA和FMA带有与吡喃并呋喃酮亚结构相连的法尼基残基。最有效的PLA2抑制剂FMA在小鼠角叉菜胶足肿胀模型中以10 mg/kg的口服剂量进行测试,显示出与参考抗炎药吲哚美辛相似的活性。